NASDAQ: UTHR
United Therapeutics Corp Stock Ownership - Who owns United Therapeutics?

Insider buying vs selling

Have United Therapeutics Corp insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Paul A. MahonEVP GENERAL COUNSEL2025-10-30393$454.15
$178.48kSell
Paul A. MahonEVP GENERAL COUNSEL2025-10-3011,000$135.42
$1.49MBuy
Paul A. MahonEVP GENERAL COUNSEL2025-10-30642$447.34
$287.19kSell
Paul A. MahonEVP GENERAL COUNSEL2025-10-301,143$448.56
$512.71kSell
Paul A. MahonEVP GENERAL COUNSEL2025-10-303,441$449.46
$1.55MSell
Paul A. MahonEVP GENERAL COUNSEL2025-10-302,247$450.64
$1.01MSell
Paul A. MahonEVP GENERAL COUNSEL2025-10-301,849$451.57
$834.95kSell
Martine A. RothblattChairperson CEO2025-10-30500$451.29
$225.65kSell
Martine A. RothblattChairperson CEO2025-10-301,459$450.23
$656.89kSell
Martine A. RothblattChairperson CEO2025-10-30541$448.43
$242.60kSell

1 of 77

UTHR insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when UTHR insiders and whales buy or sell their stock.

UTHR Shareholders

What type of owners hold United Therapeutics Corp stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc12.39%5,333,708$2.38BInstitution
Lilly Co Eli12.20%5,251,394$2.34BInsider
Vanguard Group Inc10.33%4,448,848$1.98BInstitution
Avoro Capital Advisors LLC5.50%2,370,000$1.06BInstitution
State Street Corp5.03%2,167,511$965.47MInstitution
Renaissance Technologies LLC4.92%2,119,092$943.91MInstitution
Wellington Management Group LLP3.35%1,442,936$642.73MInstitution
Aqr Capital Management LLC2.96%1,273,161$567.10MInstitution
Geode Capital Management LLC2.79%1,200,365$534.68MInstitution
Invesco Ltd2.05%884,703$394.07MInstitution

1 of 3

UTHR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
UTHR87.49%12.51%Net SellingNet Selling
GMAB99.31%0.00%
INCY77.48%22.52%Net SellingNet Selling
RPRX58.59%17.24%Net SellingNet Selling
SMMT7.01%92.99%Net BuyingNet Buying

United Therapeutics Stock Ownership FAQ

Who owns United Therapeutics?

United Therapeutics (NASDAQ: UTHR) is owned by 101.91% institutional shareholders, 14.57% United Therapeutics insiders, and 0.00% retail investors. Lilly Co Eli is the largest individual United Therapeutics shareholder, owning 5.25M shares representing 12.20% of the company. Lilly Co Eli's United Therapeutics shares are currently valued at $2.34B.

If you're new to stock investing, here's how to buy United Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.